Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systems dermatology study of vulvar premalignant and malignant disease with clobetasol-treated lichen sclerosus cohort
NL-OMON54913Phase 4Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clobetasol in Kraurosis vulvae (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Punch biopsy biomarkers, Vulvar pH and 10 more. Started Feb 2021; status: completed.
02
Drugs
clobetasol
03
Conditions
Kraurosis vulvae
Beyond the preview
Go deeper on NL-OMON54913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54913.